The BGRF will continue to support the activities of the All-Party Parliamentary Group for Longevity by offering key inputs relevant for its long-term strategy as one of its Supporting Partners
The BGRF is utilizing its expertise in pushing forward progressive policy proposals with UK politics and governance organizations within the UK to help guide the launch of similar activities in Switzerland through the Longevity Swiss Foundation, a Geneva-based non-profit aiming to make Switzerland a leading international Longevity hub.
The Biogerontology Research Foundation will participate in the construction of a comprehensive database of institutional partners relevant for the formulation and execution of the UK National Longevity Development Strategy being created by the All-Party Parliamentary Group for Longevity, in order to identify the most prospective organizations that can assist in the design and ultimate execution of the APPG’s goals to increase national HALE.
The Biogerontology Research Foundation is utilizing its wealth of knowledge on the ways that AI can be used to accelerate R&D in Preventive Medicine, Precision Health and Longevity to support the launch of AI Centres for Longevity and AI Centres for LifeTime Wellness, to make the UK a global leader in AI for Longevity Research.
The Biogerontology Research Foundation will continue its efforts on the ongoing development and optimization of its distributed knowledge platform Longevity.International for Longevity industry networking and overall cross-sector and inter-stakeholder industry optimization.
The Biogerontology Research Foundation is leveraging its 10+ years experience on the topics of AI for Longevity Research and Preventive Medicine to support the launch of the UK's first AI Longevity Centre at KIng's College in partnership with Ageing Research at King's (ARK), the APPG for Longevity and Longevity International UK.
As part of its ongoing support of the All-Party Parliamentary Group for Longevity, the Biogerontology Research Foundation will participate in the construction of a comprehensive database of all projects either funded via the UK Government, or commercial projects, relating to Longevity and Preventive Medicine which failed to achieve market-readiness of their technologies and other deliverables not due to failures in science or technology, but due to a lack of follow-up funding, in order to support cost-effective R&D to help the APPG for Longevity meet its goals.